MAP kinase kinase kinase 8 (MAP3K8; COT; TPL2); c-Met proto-oncogene (MET; HGFR); hepatocyte growth factor/scatter factor (HGF/SF) BriefCommunication Pages: 1107 - 1107
Anaplastic lymphoma kinase (ALK); nucleophosmin (NPM1; B23); platelet derived growth factor receptor A (PDGFRA; PDGFR2; CD140A); PDGFRB (PDGFR1; CD140B) BriefCommunication Pages: 1108 - 1108
X-box binding protein 1 (XBP1); endoplasmic reticulum to nucleus signaling 1 (ERN1; IRE1) BriefCommunication Pages: 1111 - 1111
Survival of motor neuron 1 telomeric (SMN1); survival of motor neuron 2 centromeric (SMN2); stasimon (STAS; CG8408) BriefCommunication Pages: 1116 - 1116
Ribosomal protein S6 kinase 70 kDa polypeptide 1 (RPS6KB1; S6K1); fragile X mental retardation 1 (FMR1) BriefCommunication Pages: 1118 - 1118
Multiplex screening for interacting compounds (MuSIC) to help identify drug combinations to treat HIV/AIDS BriefCommunication Pages: 1121 - 1121
Autologous regulatory B (Breg) cell therapy for autoimmune diseases BriefCommunication Pages: 1123 - 1123
Expansion of embryonic stem cell (ESC)-derived progenitors in organ-matched mesenchymal cultures BriefCommunication Pages: 1124 - 1124
DNA methylation signatures in chronic lymphocytic leukemia (CLL) BriefCommunication Pages: 1125 - 1125
Soluble APP770 as an early marker of acute coronary syndrome (ACS) BriefCommunication Pages: 1126 - 1126